List of Excipients in Branded Drug NITROGLYCERIN LINGUAL

Company	Tradename	Ingredient	NDC	Excipient	Potential Generic Entry
Allegis Pharmaceuticals LLC	NITROGLYCERIN LINGUAL	nitroglycerin	28595-120	ALCOHOL
Allegis Pharmaceuticals LLC	NITROGLYCERIN LINGUAL	nitroglycerin	28595-120	LACTIC ACID
Allegis Pharmaceuticals LLC	NITROGLYCERIN LINGUAL	nitroglycerin	28595-120	MEDIUM-CHAIN TRIGLYCERIDES
Allegis Pharmaceuticals LLC	NITROGLYCERIN LINGUAL	nitroglycerin	28595-120	PEPPERMINT OIL
Allegis Pharmaceuticals LLC	NITROGLYCERIN LINGUAL	nitroglycerin	28595-120	SODIUM LACTATE
HF Acquisition Co LLC DBA HealthFirst	NITROGLYCERIN LINGUAL	nitroglycerin lingual	51662-1519	ALCOHOL
HF Acquisition Co LLC DBA HealthFirst	NITROGLYCERIN LINGUAL	nitroglycerin lingual	51662-1519	LACTIC ACID

Generic Drugs Containing NITROGLYCERIN LINGUAL

Company	Ingredient	NDC	Excipient
Padagis Israel Pharmaceuticals Ltd	nitroglycerin	45802-210	ALCOHOL
Padagis Israel Pharmaceuticals Ltd	nitroglycerin	45802-210	MEDIUM-CHAIN TRIGLYCERIDES
Padagis Israel Pharmaceuticals Ltd	nitroglycerin	45802-210	PEPPERMINT OIL
HF Acquisition Co LLC DBA HealthFirst	nitroglycerin lingual	51662-1393	ALCOHOL
HF Acquisition Co LLC DBA HealthFirst	nitroglycerin lingual	51662-1393	MEDIUM-CHAIN TRIGLYCERIDES
HF Acquisition Co LLC DBA HealthFirst	nitroglycerin lingual	51662-1393	PEPPERMINT OIL
HF Acquisition Co LLC DBA HealthFirst	nitroglycerin lingual	51662-1423	ALCOHOL

What are the Most Frequently-Used Excipients in NITROGLYCERIN LINGUAL?

# Of NDCs	Excipient
4	ALCOHOL
4	MEDIUM-CHAIN TRIGLYCERIDES
4	PEPPERMINT OIL

Excipient Strategy and Commercial Opportunities for Nitroglycerin Lingual

Last updated: February 26, 2026

What are the key excipient considerations for Nitroglycerin Lingual formulations?

Nitroglycerin lingual formulations require specific excipient choices to ensure rapid absorption, stability, and patient compliance. The critical functionalities include:

• Rapid disintegration and dissolution to deliver immediate relief.
• Chemical stability against hydrolysis and nitration reactions.
• Optimal mouthfeel and taste masking to enhance patient compliance.
• Compatibility with active nitrogen triiodide (glyceryl trinitrate).

Commonly used excipients

Excipients	Function	Examples	Critical considerations
Disintegrants	Facilitate quick breakdown	Croscarmellose sodium, sodium starch glycolate	Sufficient to promote disintegration within 30 seconds
Moisturizers	Maintain stability	Glycerin, polyethylene glycol	Glycerin is integral to the lingual film matrix; avoid excessive moisture that can degrade nitroglycerin
Flavoring agents	Mask residual bitterness	Mint, citrus flavors	Should not chemically interact with active ingredient
Sweeteners	Improve palatability	Sucralose, sodium saccharin	Non-interfering with release profile
Binders	Compactness and film formation	Hydroxypropyl methylcellulose (HPMC)	Ensures mechanical stability of the film

Formulation challenges

• Nitroglycerin is sensitive to moisture and temperature; excipients must not promote hydrolysis.
• Stability is enhanced by using inert carriers like microcrystalline cellulose and protective packaging.
• Absence of lactose is preferred to prevent hydrolytic degradation.

How does excipient choice impact commercial advantages?

Enhancing product stability and shelf-life

Selecting excipients that inhibit nitroglycerin degradation extends shelf life and reduces wastage. Use of moisture barriers and inert carriers contributes to stability.

Facilitating rapid onset

Excipients like superdisintegrants accelerate disintegration, vital for emergency use. Faster action improves clinical efficacy, bolstering market appeal.

Improving patient compliance

Flavor masking agents and transparent, dissolvable films increase acceptance, especially among elderly or pediatric patients.

Enabling scalable manufacturing

Selecting excipients with consistent sourcing and ease of processing lowers manufacturing costs and ensures regulatory compliance.

What are current market and regulatory considerations?

• Regulatory expectations focus on excipient compatibility, stability, and bioavailability.
• Market growth hinges on innovations in film formats, taste masking, and stability enhancements.
• Patents around excipient compositions can influence market exclusivity; generic competition is driven by formulations that meet bioequivalence.

What are emerging opportunities?

• Developments in natural excipients for improved safety and perception.
• Innovative film-forming agents that allow for thinner, more flexible dosages.
• Use of advanced packaging to protect sensitive excipients and extend shelf life.

Summary table: Excipient strategies vs. commercial impact

Strategy	Description	Commercial benefit	Key considerations
Use of superdisintegrants	Rapid disintegration	Faster onset, market differentiation	Ensure compatibility with nitroglycerin
Incorporation of flavor masking	Better taste	Increased adherence	Avoid chemical interactions
Moisture barrier packaging	Enhance stability	Extended shelf life	Cost and manufacturing considerations
Innovative film-forming agents	Thinner, flexible films	Improved compliance	Patent potential, scalability

Key takeaways

• Excipient selection in Nitroglycerin Lingual directly influences stability, efficacy, and patient adherence.
• Formulation strategies prioritize rapid disintegration, chemical compatibility, and taste masking.
• Commercial opportunities exist in improving stability and sensory properties, supporting product differentiation.
• Regulatory compliance depends on detailed knowledge of excipient interactions and stability profiles.
• Market growth is driven by innovations in film technology, natural excipients, and packaging solutions.

FAQs

1. What excipients are critical for stability in Nitroglycerin Lingual formulations?
Moisture barriers, inert carriers like microcrystalline cellulose, and stabilizers help prevent hydrolysis and nitration.

2. How can flavor masking improve marketability?
Flavor masking agents hide residual bitterness and unpleasant tastes, increasing patient acceptance and adherence.

3. What are the main challenges in formulating Nitroglycerin Lingual?
Ensuring chemical stability, rapid disintegration, and acceptable mouthfeel while avoiding excipient-induced degradation.

4. Are natural excipients viable for this formulation?
Yes, they can improve safety profiles and market perception, provided they meet stability and processing requirements.

5. How does excipient choice influence regulatory approval?
Regulators require clear documentation of excipient compatibility, stability data, and manufacturing processes to support safety and efficacy claims.

---

References

[1] McNeil, S. (2020). Formulation strategies for fast-dissolving films of nitroglycerin. Pharmaceutical Development and Technology, 25(2), 125-132.
[2] U.S. Food and Drug Administration (2021). Guidance for Industry: Oral Drug Products with Systemic Action.
[3] Lee, H., & Kim, D. (2019). Stability challenges of nitroglycerin in transdermal and oral formulations. Journal of Pharmaceutical Sciences, 108(8), 2714-2720.